611 related articles for article (PubMed ID: 15384126)
21. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
[TBL] [Abstract][Full Text] [Related]
22. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
[TBL] [Abstract][Full Text] [Related]
23. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
[TBL] [Abstract][Full Text] [Related]
24. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
25. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
[TBL] [Abstract][Full Text] [Related]
26. Neurostimulation for Parkinson's disease with early motor complications.
Schuepbach WM; Rau J; Knudsen K; Volkmann J; Krack P; Timmermann L; Hälbig TD; Hesekamp H; Navarro SM; Meier N; Falk D; Mehdorn M; Paschen S; Maarouf M; Barbe MT; Fink GR; Kupsch A; Gruber D; Schneider GH; Seigneuret E; Kistner A; Chaynes P; Ory-Magne F; Brefel Courbon C; Vesper J; Schnitzler A; Wojtecki L; Houeto JL; Bataille B; Maltête D; Damier P; Raoul S; Sixel-Doering F; Hellwig D; Gharabaghi A; Krüger R; Pinsker MO; Amtage F; Régis JM; Witjas T; Thobois S; Mertens P; Kloss M; Hartmann A; Oertel WH; Post B; Speelman H; Agid Y; Schade-Brittinger C; Deuschl G;
N Engl J Med; 2013 Feb; 368(7):610-22. PubMed ID: 23406026
[TBL] [Abstract][Full Text] [Related]
27. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G
Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in patients with Parkinson's disease.
Behari M; Srivastava AK; Pandey RM
Parkinsonism Relat Disord; 2005 Jun; 11(4):221-6. PubMed ID: 15878582
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
Reichmann H; Boas J; Macmahon D; Myllyla V; Hakala A; Reinikainen K;
Acta Neurol Scand; 2005 Jan; 111(1):21-8. PubMed ID: 15595934
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of deep-brain stimulation for Parkinson's disease.
Deuschl G; Schade-Brittinger C; Krack P; Volkmann J; Schäfer H; Bötzel K; Daniels C; Deutschländer A; Dillmann U; Eisner W; Gruber D; Hamel W; Herzog J; Hilker R; Klebe S; Kloss M; Koy J; Krause M; Kupsch A; Lorenz D; Lorenzl S; Mehdorn HM; Moringlane JR; Oertel W; Pinsker MO; Reichmann H; Reuss A; Schneider GH; Schnitzler A; Steude U; Sturm V; Timmermann L; Tronnier V; Trottenberg T; Wojtecki L; Wolf E; Poewe W; Voges J;
N Engl J Med; 2006 Aug; 355(9):896-908. PubMed ID: 16943402
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
Siderowf A; Jaggi JL; Xie SX; Loveland-Jones C; Leng L; Hurtig H; Colcher A; Stern M; Chou KL; Liang G; Maccarone H; Simuni T; Baltuch G
Mov Disord; 2006 Jun; 21(6):746-53. PubMed ID: 16463342
[TBL] [Abstract][Full Text] [Related]
32. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
33. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
[TBL] [Abstract][Full Text] [Related]
34. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease.
Fabbrini G; Defazio G; Colosimo C; Suppa A; Bloise M; Berardelli A
Mov Disord; 2009 Oct; 24(14):2091-6. PubMed ID: 19691126
[TBL] [Abstract][Full Text] [Related]
35. Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life.
Puente V; De Fabregues O; Oliveras C; Ribera G; Pont-Sunyer C; Vivanco R; Cucurella G; Giralt E; Delgado T; Garcia C; Seoane A; Campo R
Parkinsonism Relat Disord; 2010 Mar; 16(3):218-21. PubMed ID: 19762271
[TBL] [Abstract][Full Text] [Related]
36. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
[TBL] [Abstract][Full Text] [Related]
38. Predictors and course of health-related quality of life in Parkinson's disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Herlofson K; Alves G
Mov Disord; 2008 Jul; 23(10):1420-7. PubMed ID: 18512757
[TBL] [Abstract][Full Text] [Related]
39. The clinically important difference on the unified Parkinson's disease rating scale.
Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
[TBL] [Abstract][Full Text] [Related]
40. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
